Belite Bio Inc (BLTE)

AI Score

Unlock

56.40

-0.88 (-1.54%)

At close: Apr 17, 2025, 3:59 PM

57.00

1.07%

Pre-market: Apr 21, 2025, 04:00 AM EDT

Belite Bio Inc Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	May 31, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cash & Equivalents	31.68M	n/a	95.5M	95.5M	88.16M	54.5M	57.4M	37.8M	42.09M	42.09K	48.7K	-17.34M	17.34M	17.34M	21.99M	21.99M	25.62M	25.62M	6.4M	6.4M
Short-Term Investments	113.47M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	34.69M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	103K	4.55M	4.57M	4.68M	166K	1.46M	1.56M	1.4M	57K	-1.35K	1.13M	-17.34M	823K	823K	11K	11K	27K	27K	1.75K	1.75K
Receivables	594K	n/a	n/a	n/a	867K	n/a	n/a	n/a	19K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10K	10K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	698.28K	n/a	n/a	n/a	n/a	-5.75K	-5.75K	-5.75K	-10K	-10K	n/a	n/a
Other Current Assets	n/a	111.27M	113.86M	96.47M	n/a	56.13M	59.14M	38.42M	n/a	718.00	1.23M	n/a	n/a	23K	20K	20K	40K	40K	2.5K	2.5K
Total Current Assets	147.07M	111.27M	113.86M	96.47M	89.94M	56.13M	59.14M	38.42M	42.81M	42.81K	49.93M	17.34M	17.43M	17.43M	22.04M	22.04M	25.67M	25.67M	6.42M	6.42M
Property-Plant & Equipment	965K	n/a	n/a	n/a	1.3M	n/a	n/a	n/a	1.38M	1.35K	n/a	n/a	94K	94K	114K	114K	46K	46K	16.5K	16.5K
Goodwill & Intangibles	3.99M	n/a	n/a	n/a	3.23M	n/a	n/a	n/a	31K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.06M	4.55M	4.57M	4.68M	4.7M	1.46M	1.56M	1.4M	1.47M	1.35K	1.13M	-17.34M	917K	917K	125K	125K	73K	73K	18.25K	18.25K
Total Assets	152.13M	115.82M	118.43M	101.15M	94.64M	57.6M	60.7M	39.82M	44.27M	44.27K	51.06M	n/a	18.35M	18.35M	22.17M	22.17M	25.74M	25.74M	6.44M	6.44M
Account Payables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	992K	n/a	n/a	n/a	149K	n/a	n/a	n/a	74K	2.1K	n/a	n/a	24K	95K	15K	15K	5K	5K	243K	243K
Total Current Liabilities	6.05M	n/a	3.84M	4.68M	3.63M	4.8M	4.98K	4.65M	2.1M	2.1K	1.43K	n/a	1.64M	1.64M	997K	997K	972K	972K	243K	243K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	31.81M	n/a	n/a	n/a	n/a	n/a	7.95M	7.95M
Total Long-Term Liabilities	261K	n/a	n/a	4.68M	578K	4.8M	4.98M	n/a	668K	n/a	1.43M	n/a	31.81M	7.95M	7.95M	7.95M	7.95M	7.95M	7.95M	7.95M
Total Liabilities	6.31M	3.62M	3.84M	4.68M	4.21M	4.8M	4.98M	4.65M	2.77M	2.77K	1.43M	n/a	33.44M	1.64M	997K	997K	972K	972K	8.19M	8.19M
Total Debt	537K	n/a	n/a	n/a	886K	n/a	n/a	n/a	866K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	3K	n/a	114.59M	96.47M	3K	52.79M	55.72K	35.17K	3K	3.00	49.63K	n/a	1K	1K	1K	1K	1K	1K	250.00	250.00
Retained Earnings	-107.65M	n/a	n/a	n/a	-71.5M	n/a	n/a	n/a	-39.87M	-39.87K	n/a	n/a	-27.22M	-27.22M	-22.28M	-22.28M	-17.56M	-17.56M	-4.39M	-4.39M
Comprehensive Income	-660K	n/a	n/a	n/a	-374K	n/a	n/a	n/a	-392K	n/a	n/a	-15.09M	-196K	-196K	-131K	-131K	-44K	-44K	-11.5K	-11.5K
Shareholders Equity	145.82M	112.2M	114.59M	96.47M	90.43M	52.79M	55.72M	35.17M	41.5M	41.5K	49.63M	16.71M	-15.09M	16.71M	21.17M	21.17M	24.77M	24.77M	-1.76M	-1.76M
Total Investments	113.47M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	34.69M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a